The injection requirement for most peptide drugs may limit their use in certain patient populations, such as those with needle phobias or limited ability to self-administer injections
"Meijer is proud to offer greater access to GLP-1 medications at a price that allows individuals to take charge of their health, and our team is equipped with the knowledge our customers need when selecting GLP-1 treatments." For more information, customers are encouraged to visit their local Meijer pharmacy
In a clinical trial with 959 patients treated with OZEMPIC 1 mg or OZEMPIC 2 mg once weekly as add-on to metformin with or without sulfonylurea treatment for 40 weeks, no new safety signals were identified
Cytokine levels were measured using enzyme-linked immunosorbent (ELISA) assay kits: Human 1L-10 ELISA Ready-SET-Go from Affymetrix (Cat# 88-7106) and Human TNF- Uncoated ELISA (Cat # 88-7346), Human IFN- Uncoated ELISA (Cat # 88-7316), and Human IL-6 Uncoated ELISA (Cat # 88-7066) from Invitrogen to quantity detection of cytokines
Orforglipron represents the next evolution in this space as a highly effective, non-peptide oral GLP-1 receptor agonist
